Abstract
As is amply illustrated in other chapters in this volume, Paul Ehrlich (1854–1915) was a key figure in the introduction of new methods to standardize drugs at the end of the nineteenth century. Starting in the 1890s, the Berlin bacteriologist and immunologist created a method to measure the efficacy of therapeutic sera. This method had a wide impact on scientific medicine in the twentieth century, but for Ehrlich it constituted just one step, albeit a very important one, in his intellectual and scientific career. This paper argues for the importance of Ehrlich’s method for medicine in general, and, more particularly that it was representative of developments in nineteenth-century scientific medicine that prepared the ground for the rise of biomedicine in the twentieth century. In this respect, Ehrlich’s standardization method participated in an ensemble of fundamental cultural changes that underwrote scientific medicine.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Notes
Anthony S. Travis, ‘Science as Receptor of Technology: Paul Ehrlich and the Synthetic Dyestuffs Industry’, Science in Context 3 (1989), pp. 383–408
Dolman, ‘Paul Ehrlich’, p. 297. for Carl Gerhardt, see also: ‘Professor Carl Gerhardt’, Lokal-Anzeiger 20 (1902), No. 337, Berlin, July 22, 1902, p. 1
Jonathan Liebenau, ‘Paul Ehrlich as a commercial Scientist and Research Administrator’, Medical History 34 (1990), pp. 65–78
For a general overview of the history of the receptor concept, see: John Parascandola and Ronald Jasensky, ‘Origins of the Receptor Theory of Drug Action’, Bulletin of the History of Medicine 48 (1974), pp. 199–220
Ibid.; For Ehrlich and clinical pathology, see also: Cay-Rüdiger Prüll, ‘Paul Ehrlich als klinischer Pathologe’, Praxis. Schweizerische Rundschau für Medizin 93 (2004), pp. 1706–14.
See the papers of Anne I. Hardy, Axel Hüntelmann and Jonathan Simon in this volume. For the impact of Ehrlich’s collaboration with representatives of politics and industry on his standardization procedure, see also: Anne I. Hardy, ‘Paul Ehrlich und die Serumproduzenten: Zur Kontrolle des Diphtherieserums in Labor und Fabrik’, Medizinhistorisches Journal 41 (2006), pp. 51–84.
Editor information
Editors and Affiliations
Copyright information
© 2010 Cay-Rüdiger Prüll
About this chapter
Cite this chapter
Prüll, CR. (2010). Paul Ehrlich’s Standardization of Serum: Wertbestimmung and Its Meaning for Twentieth-Century Biomedicine. In: Gradmann, C., Simon, J. (eds) Evaluating and Standardizing Therapeutic Agents, 1890–1950. Science, Technology and Medicine in Modern History. Palgrave Macmillan, London. https://doi.org/10.1057/9780230285590_2
Download citation
DOI: https://doi.org/10.1057/9780230285590_2
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-30087-7
Online ISBN: 978-0-230-28559-0
eBook Packages: Palgrave History CollectionHistory (R0)